Roger Perlmutter Town Hall

[Anonymous]

In his E-mail today, Rupert is heading Discovery and Rich Tillya still heading the Preclinical. All the franchises are gone. I was disappointed he didn't make more leadership changes, since we're not going to be able to get rid of the abusive low morale creating middle managers if he still has the same leadership on top. I was impressed with his talks though, and hope he has some real way of restoring dignity to the bench scientists as he talked about (before they all leave).

what about Boston? Is the Montreal guy still in charge there?

 

[Anonymous]

What about D Nicholson?

 

[Anonymous]

what about Boston? Is the Montreal guy still in charge there?

He needs to be on the hit list.

 

[Anonymous]

What about D Nicholson?

LOL!!!!!!

 

[Anonymous]

He needs to be on the hit list.

Gary O'Neill will be gone (as of July).

 

[Anonymous]

Please elaborate. Is Gary promoted or demoted? A very low key guy at playing the right cards to please his masters.

 

[Anonymous]

gone ….

 

[Anonymous]

Onc pretty much dead. Steve has been let go couple month ago, Gary G … gone, Leigh gone … more info next week ….. Guess research is now run by the two with funny british accents, and yes they are tall, very important

 

[Anonymous]

Research Leadership Team (RLT) GO TEAM......LOL

Rupert Vessey will lead Discovery and Early Development, including biology research necessary to identify targets, medicinal chemistry for the elaboration of therapeutics with ideal pharmaceutical properties, and early clinical development activities designed to characterize the behavior of these compounds in human subjects,

Rich Tillyer will have responsibility for Preclinical Development, including process chemistry. As previously announced, Rich has also assumed a corporate responsibility as part of the team, led by Willie Deese, that is developing an improved operating model for Merck & Co,

Linda Schaffer will lead our Project Management group, and will have responsibility for all of our performance metrics. Project teams that previously reported through Linda’s group will now move to their respective development areas, as appropriate. Linda will also serve as the project lead for the team led by Willie Deese, on which Rich Tillyer also serves,

Barry Gertz will head the Clinical Development organization, including clinical operations, the clinical therapeutic areas, and the Japan development organization,

Dennis Erb will be responsible for our Regulatory Affairs and Safety organization, which will be expanded to include our emerging market activities,

Rich Murray will lead research in Biologics and Vaccines, including process development activities necessary to provide materials for clinical trials and the transfer of commercially viable manufacturing processes to MMD,

I am elevating the Licensing organization to report directly to me. I intend to reconfigure this group to adopt a more operational focus. An external search for a new head of licensing is underway and will be the subject of a future announcement. Roger Pomerantz will continue to lead this function during this interim period.

 

[Anonymous]

Please elaborate. Is Gary promoted or demoted? A very low key guy at playing the right cards to please his masters.

Synonymous for passive aggressive behavior.

 

[Anonymous]

How do you know Leigh is gone? Has that been announced?

 

[Anonymous]

Synonymous for passive aggressive behavior.[/QUOTE

He is such a politically correct guy. Never heard a single honest word from him in my many years working with him. So fake!

 

[Anonymous]

How do you know Leigh is gone? Has that been announced?

What about those middle level managers from Merck Frosst, such as the Head of Pharmacology who has zero in vivo experience?

 

[Anonymous]

What about those middle level managers from Merck Frosst, such as the Head of Pharmacology who has zero in vivo experience?

One of Metter's Black Angels!

 

[Anonymous]

Cannot believe that she would be even in that position. I guess that 6 Sigma made her a good leader for everything.

 

[Anonymous]

Cannot believe that she would be even in that position. I guess that 6 Sigma made her a good leader for everything.

She would be O'Neill's successor if any of her supporters were still within MRL or weren't busy covering their own asses at this time.

 

[Anonymous]

she is such a useful control freak

 

[Anonymous]

Finally, the Montreal Mafia is broken. The capos are gone and the remaining foot soldiers are running scared. With new therapeutic area leadership, this is Boston's last chance to deliver. At least science has a real chance to breathe now. Before, the emphasis was always on milestones (get there whatever the cost) and flashy PowerPoint presentations ('hide the negative results!'). Roger will sniff out the remaining rats and BS artists in no time. The few true scientists left in Boston are really looking forward to the next few months. Let's hope this is not a false dawn.

 

[Anonymous]

Finally, the Montreal Mafia is broken. The capos are gone and the remaining foot soldiers are running scared. With new therapeutic area leadership, this is Boston's last chance to deliver. At least science has a real chance to breathe now. Before, the emphasis was always on milestones (get there whatever the cost) and flashy PowerPoint presentations ('hide the negative results!'). Roger will sniff out the remaining rats and BS artists in no time. The few true scientists left in Boston are really looking forward to the next few months. Let's hope this is not a false dawn.

Haha, remember them talking about leadership on every occasion? It is science, stupid!

 

[Anonymous]

Haha, remember them talking about leadership on every occasion? It is science, stupid!

People who do not have leadership like to pretend to have it by talking about it all the time. This is basically what happened with the Montreal mafia at MRL Boston.